Management of Glaucoma: Effective Drug Delivery via Niosomes

Abstract

Glaucoma is a term used for a group of diseases; associated with optic nerve damage which leads to loss of retinal ganglionic cells. Niosomes which are nano-sized, non-ionic surfactant vesicles, offer a superior drug delivery system for glaucoma by overcoming traditional eye drop limitations like rapid drainage and poor penetration, leading to sustained drug release, prolonged ocular residence, better patient compliance, and reduced side effects by encapsulating drugs like latanoprost or brimonidine within their bilayers, enhancing drug availability at the target site to effectively lower intraocular pressure (IOP) and prevent blindness.